Allogene Therapeutics (ALLO) announced the publication of data from its Phase 1 ALPHA and ALPHA2 clinical studies of cemacabtagene ...
Campaigners say children in study would be ‘treated worse than guinea pigs’ because drugs’ harms are well known ...
New drugs for early Alzheimer’s disease may allow people to live without help for up to 39 additional months, a new study estimates. But experts urge caution.
While a federal judge has paused the funding cuts, the uncertainty has researchers concerned about the future of scientific ...
The drug semaglutide has been linked to a lower risk of alcoholism before, but now we have strong evidence that it really ...
For years, people taking Ozempic or other drugs in the same class for diabetes and weight loss have noticed the medicines don ...
Moderna has been ordered to pay almost £44,000 after 12-year-olds were encouraged to join Covid vaccine trials with the ...
Pfizer (PFE) and Astellas Pharma announced additional follow-up results from the Phase 3 EV-302 clinical trial evaluating the efficacy and ...
A trial that will test a noninvasive device called MyoRegulator as a treatment for ALS was cleared to start enrolling ...
A Phase 2 clinical trial testing obexelimab in adults with relapsing types of multiple sclerosis is now recruiting ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback